How do immunosuppressant drugs help prevent organ rejection?

The human immune system is designed to protect the body by identifying and attacking foreign materials, such as bacteria and viruses. Unfortunately, it cannot distinguish between these harmful invaders and the cells of a lifesaving transplant, perceiving the new organ as a threat.1

Immunosuppressant drugs help prevent organ rejection by inhibiting the immune system's ability to attack the graft. Because rejection is primarily driven by cell-mediated immunity—where T lymphocytes infiltrate and destroy foreign tissue—these drugs target the pathways that activate these cells.234

Common mechanisms include:
* Calcineurin inhibitors: These block intracellular signaling pathways required for T cell activation.2
* Antiproliferative and antimetabolic agents: These interfere with the synthesis of DNA or RNA, preventing the multiplication of immune cells.25
* Antibody therapies: These bind to specific proteins on the surface of T cells or neutralize signaling molecules like cytokines to dampen the immune response.2

By suppressing these responses, the drugs allow the recipient's body to accept the transplant, though this requires a careful balance to avoid leaving the patient overly susceptible to infections.35